Deflazacort: Therapeutic index, relative potency and equivalent doses versus other corticosteroids

57Citations
Citations of this article
100Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Deflazacort is a synthetic corticosteroid characterized by a favourable pharmacokinetic profile, peculiar pharmacodynamic properties and a good safety profile. However, to the best of our knowledge, no dose-conversion table based on direct comparison of relative potencies between deflazacort and other main corticosteroids is currently available in scientific literature. Main body: This paper, while reporting a brief review of deflazacort pharmacological properties, its efficacy and tolerability in different clinical areas, has been designed with the specific aim of providing a new dose-conversion table of corticosteroids, including for the first time also deflazacort. Short conclusion: We suggest that this new conversion table could be a useful tool for physicians who need to select the appropriate dose of deflazacort in their clinical practice.

Cite

CITATION STYLE

APA

Parente, L. (2017). Deflazacort: Therapeutic index, relative potency and equivalent doses versus other corticosteroids. BMC Pharmacology and Toxicology, 18(1). https://doi.org/10.1186/s40360-016-0111-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free